Comparison of the ability of dopamine receptor agonists to inhibit forskolin-stimulated adenosine 3'5'-cyclic monophosphate (cAMP) accumulation via D(2L) (long isoform) and D3 receptors expressed in Chinese hamster ovary (CHO) cells

Biochemical Pharmacology

Volumn 58, Issue 2, 1999, Pages 285-289

  Hall, David A ^a   Strange, Philip G ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Adenylyl cyclase; D(2L) receptor; D3 receptor; Dopamine

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; ADENOSINE; ADENYLATE CYCLASE; APOMORPHINE; BROMOCRIPTINE; CYCLIC AMP; DIHYDROERGOCRISTINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FORSKOLIN; PRECLAMOL; PROPYLNORAPOMORPHINE; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CHO CELL; CONCENTRATION RESPONSE; DRUG POTENCY; DRUG RECEPTOR BINDING; ENZYME INHIBITION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY;

ANIMALS; CHO CELLS; CRICETINAE; CYCLIC AMP; DOPAMINE; DOPAMINE AGONISTS; FORSKOLIN; HUMANS; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TRANSFECTION;

EID: 0033566268     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00101-X     Document Type: Article

References (22)

1. Strange P.G. Brain Biochemistry and Brain Disorders. 1992;Oxford University Press, Oxford.
2. Sibley D.R., Monsma F.J. Molecular biology of dopamine receptors. Trends Pharmacol Sci. 13:1992;61-69.
3. Civelli O., Bunzow J.R., Grandy D.K. Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol. 32:1993;281-307.
4. 3 dopamine receptor generated by alternative splicing in the third intracellular loop. J Biol Chem. 268:1993;5872-5878.
5. Seeman P., Van Tol H.H.M. Dopamine receptor pharmacology. Trends Pharmacol Sci. 15:1994;264-270.
6. 2 dopamine receptor. Trends Pharmacol Sci. 10:1989;74-77.
7. 2 (short) dopamine receptors determined in ligand binding and functional assays. J Neurochem. 69:1997;2589-2598.
8. 3) as a target for neuroleptics. Nature. 347:1990;146-151.
9. 3 dopamine receptor Pharmacological properties and development of antibodies . J Pharmacol Exp Ther. 264:1993;1002-1011.
10. 3 dopamine receptor. J Pharmacol Exp Ther. 268:1994;417-426.
11. 3 receptor expressed in transfected cell lines. Eur J Pharmacol Mol Pharmacol Sect. 266:1994;79-85.
12. 3 dopamine receptors. Neuropsychopharmacology. 12:1995;335-345.
13. 1 pituitary cells. FEBS Lett. 312:1992;123-126.
14. 3 dopamine receptors to G-proteins. FEBS Lett. 315:1993;223-226.
15. 3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. Eur J Pharmacol Molec Pharmacol Sect. 268:1994;129-139.
16. 2 dopamine receptors . Mol Pharmacol. 45:1994;51-60.
17. 3 receptor. Synapse. 21:1995;1-9.
18. 3-dopamine receptor is negatively coupled to adenylyl cyclase. Br J Pharmacol. 114:1995;344.
19. Sokoloff P., Schwartz J.-C. Novel dopamine receptors half a decade later. Trends Pharmacol Sci. 16:1995;270-275.
20. 2 receptors. Neuroreport. 6:1995;329-332.
21. B subtypes in a heterologous cell line . Mol Endocrinol. 6:1992;920-926.
22. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 58:1974;541-548.